thelancet.com/journals/land...
Teprotumumab for patients with active thyroid eye disease: a pooled data analysis, subgroup analyses, and off-treatment follow-up results from two randomised, double-masked, placebo-controlled, multicentre trials
The knowns and unknowns of teprotumumab for thy... - Thyroid UK
The knowns and unknowns of teprotumumab for thyroid eye disease
Written by
ling
To view profiles and participate in discussions please or .
1 Reply
•
helvellaAdministrator
I am sorry that you do not appear to have received a timely response to your post/question - or perhaps you got an answer on another post or in a Private Message? Please feel free to post a new question if you wish. Posts are sometimes missed as it is so busy. Or maybe no-one who read it was able to answer?
Please do not feel the need to respond.
Thanks for posting - it is good to know that research continues.
Not what you're looking for?
You may also like...
Article from the Lancet re covid-19 and thyroid
This might not be new but I've only just seen it and thought it might be of interest. If anyone...
Access to the Lancet?
Just wondering if Thyroid UK has access to the Lancet. There's a new article suggesting the overuse...
Reference intervals in the diagnosis of thyroid dysfunction: treating patients not numbers
A new article by Prof Jonklaas. Some hope perhaps. The full article is behind a paywall. Perhaps...
Vitamin D supplements don't help bone health, major study concludes
Yesterday's fact transmutes into today's non-fact!
Do note that the other possible benefits of...
Treatment for finger-bending disease may be ‘gamechanger’
I know that Dupuytren's has been mentioned more than a couple of times but cannot locate any...
Thyroid Eye disease & Statins
Potential effects of TSH suppression for thyroid cancer
